Skip to main content
Sister Publication Links
  • ESG: THE IMPLEMENTATION IMPERATIVE
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Digital Health
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Transformation
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Unwell in America
  • Opinion
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • Data Center
    • Data Center Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Insurance
February 19, 2020 03:58 PM

Oscar joins other health insurers in capping insulin costs

Shelby Livingston
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Getty Images

    New York-based Oscar Health is the latest insurer to cap some plan members' out-of-pocket costs for life-saving insulin and other medications, a move several insurance companies have made in the last year amid pressure to reduce prescription drug costs.

    Oscar announced Wednesday that its individual insurance plan members will now pay $3 for a month's supply of 100 commonly used drugs. In addition to insulin, a high-cost drug is used to treat Type 1 diabetes, the list includes drugs to treat Type 2 diabetes, migraines, nausea, allergies and high blood pressure, among other medical conditions.

    Lowering patients' copays makes it more likely they will take their medications, which means fewer costly visits to the doctor's office and emergency department, Oscar said in a blog post explaining its motivation.

    "Solving this problem is good for business, but making sure people have access to medication at a reasonable price isn't a matter of economics, it's a matter of ethics," Oscar CEO Mario Schlosser said.

    Other health insurers and pharmacy benefit managers have taken similar steps to help patients afford their medications, particularly insulin. The rising cost of insulin has come under scrutiny from policymakers, who have grilled drug manufacturers over their list prices and introduced legislation to reduce the cost of the essential drug. Some states, including Colorado and most recently, Illinois, have enacted laws capping insulin copayments for patients, as well. Other states are mulling such legislation.

    Capping co-payments for insulin and other expensive medications is helpful to the limited number of patients covered by those participating insurers and employers. But copay caps do not address the underlying price of the drug and offer no help to patients who are covered by other health plans or who are uninsured.

    "It doesn't bring down high list prices, which are paid by people without insurance and those who are in the deductible phase of their health plan and are not in a state or health plan that has enacted a cap on monthly out-of-pocket spending," said Jeannie Fuglesten Biniek, a senior researcher at the Health Care Cost Institute. "Additionally, it does nothing to improve the opacity of drug pricing or increase competition in the insulin market."

    Insurers' programs reducing the cost of insulin and other drugs typically affect only a narrow slice of their membership. In Oscar's case, the $3 drug formulary will benefit about half of the insurer's 420,000 members with individual coverage. It won't be available to members in New York, New Jersey or California because of state regulations, a company spokeswoman explained, and it won't affect patients enrolled in individual catastrophic plans, Medicare or small business plans.

    The much larger Cigna and CVS Health also introduced programs to cap or eliminate copayments for diabetes medications, but in both cases patients will benefit only if their employers opt in. Cigna, along with its pharmacy benefit manager Express Scripts, this year allows employers the option to offer members a 30-day supply of insulin for $25, which is about 40% less than what most Cigna members paid previously. The discount could affect up to 700,000 people, a company spokeswoman said at the time of the announcement.

    CVS Health, owner of insurer Aetna, plans to eliminate out-of-pocket costs for all prescription diabetes medications for members whose pharmacy benefits are managed by the company's PBM, starting in 2021. A CVS spokesman did not say how many patients would be affected, as the company is still in active discussions with clients.

    Minnetonka, Minn.-based not-for-profit insurer Medica capped a month's worth of insulin at a $25 copayment for 7,500 fully insured individual and employer group members in Minnesota, North Dakota, South Dakota and Wisconsin.

    Meanwhile, in the absence of any federal relief, states have stepped up to protect patients from high drug prices. Starting Jan. 1, Colorado became the first state to cap commercially insured patients' copays for insulin at $100 per month regardless of how much they need. Insurers must absorb the rest of the cost. An Illinois bill signed into law in January limits insulin copays at $100 per month for people covered by commercial health plans. Bills being debated in California and Minnesota would implement similar copay caps.

    According to the Health Care Cost Institute, the cost to manage Type 1 diabetes, which affects more than 1.2 million people, rose from $12,467 per person in 2012 to $18,494 in 2016. Spending on insulin drove that increase. Average annual out-of-pocket spending for insulin grew from $2,864 to $5,705 per person over that period, according to HCCI.

    Unlike the majority of patients with Type 2 diabetes who can improve the effects of the disease and lessen their dependence on insulin through healthier diet and exercise, Type 1 patients do not make insulin and require several doses a day.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    health insurance form with stethoscope 800x533.jpg
    Major insurers to ease prior authorizations ahead of federal crackdown
    Clawbacks
    Insurance companies ramp up efforts to claw back money from providers
    Most Popular
    1
    More healthcare organizations at risk of credit default, Moody's says
    2
    Centene fills out senior executive team with new president, COO
    3
    SCAN, CareOregon plan to merge into the HealthRight Group
    4
    Blue Cross Blue Shield of Michigan unveils big push that lets physicians take on risk, reap rewards
    5
    Bright Health weighs reverse stock split as delisting looms
    Sponsored Content
    Daily Finance Newsletter: Sign up to receive daily news and data that has a direct impact on the business and financing of healthcare.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Digital Health
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Unwell in America
    • Opinion
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top 25 Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • Data Center
      • Data Center Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing